NEWRON PHARMACEUT. EO-20 (NP5) — Cash Flow Reinvestment Rate
NEWRON PHARMACEUT. EO-20 (NP5) has a Cash Flow Reinvestment Rate of 0.00x as of June 2025, reinvesting €31.00K (capex €31.00K ) from operating cash flow of €33.60 Million. Explore NP5 capital expenditure intensity to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
NEWRON PHARMACEUT. EO-20 Cash Flow Reinvestment Rate (2012–2012)
Historical reinvestment intensity for NEWRON PHARMACEUT. EO-20 across 1 annual periods. Also explore NP5 asset base for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for NEWRON PHARMACEUT. EO-20 (2012–2012)
Year-by-year capital reinvestment analysis for NEWRON PHARMACEUT. EO-20. For live market cap and broader valuation context, see market cap of NEWRON PHARMACEUT. EO-20.
| Year | Reinvestment Rate | Total Reinvested (EUR) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2012 | 0.00x | €11.00K | €5.83 Million | €11.00K | — |